In an embalming student with nightly nightmares related to embalming for the past eight months, would prazosin be an appropriate treatment?

Prazosin May Be Considered for This Student's Nightmares, Though Image Rehearsal Therapy Should Be First-Line

Prazosin may be used for this embalming student's nightmare disorder, but image rehearsal therapy (a form of cognitive behavioral therapy) is the only recommended first-line treatment and should be prioritized. 1

Understanding the Clinical Picture

This student meets diagnostic criteria for nightmare disorder based on the 2018 American Academy of Sleep Medicine guidelines 1:

• Repeated dysphoric dreams (nightly for 8 months)
• Related to specific content (embalming work)
• Causing functional impairment (occupational/educational impact implied)

Critical distinction: These are not PTSD-associated nightmares. The student has work-related distressing dreams but no indication of trauma exposure meeting PTSD criteria. This matters because the evidence base differs.

Treatment Algorithm

Step 1: Image Rehearsal Therapy (Recommended - Level A)

• This is the only therapy with a "recommended" designation for nightmare disorder 1
• Involves rescripting nightmares while awake and rehearsing new, less distressing versions
• Should be attempted before pharmacotherapy

Step 2: Consider Prazosin if Psychotherapy Insufficient

According to 2018 AASM guidelines, prazosin "may be used" for nightmare disorder (not PTSD-associated) 1. This is a weaker recommendation than for PTSD-related nightmares.

Prazosin Specifics for Non-PTSD Nightmare Disorder

Dosing approach 2:

• Always start with 1 mg at bedtime (the 2 mg and 5 mg capsules are NOT for initial therapy) 3
• Increase by 1-2 mg every few days based on response
• Effective doses typically range 1-10 mg (average ~3 mg for civilians)
• Higher doses (up to 15-20 mg) used in some studies but primarily for PTSD populations

Evidence quality concerns: The evidence for prazosin in non-PTSD nightmare disorder is substantially weaker than for PTSD-related nightmares. The 2018 guidelines downgraded prazosin's recommendation after a large 304-patient VA study showed no benefit over placebo 1. However, this study had important limitations:

• 78% were on concurrent antidepressants (which may interfere with prazosin efficacy) 1
• Many clinicians observe excellent individual responses despite mixed trial results 1

Safety Monitoring Required

Critical warnings from FDA label 3:

• Syncope risk: ~1% incidence with initial doses ≥2 mg (hence the mandatory 1 mg start)
• Usually occurs 30-90 minutes after first dose
• Patient should be counseled to avoid situations where injury could occur if syncope develops
• Monitor for orthostatic hypotension and dizziness
• Rare but serious: priapism (seek immediate care if erection >4 hours)

Practical monitoring:

• Check blood pressure sitting and standing at follow-up
• Advise taking first dose when able to remain recumbent if needed
• Warn about dizziness/lightheadedness

Important Caveats

1. This is off-label use: Prazosin is FDA-approved for hypertension, not nightmares
2. Weaker evidence for non-PTSD nightmares: Most robust data is in PTSD populations 1
3. Recent meta-analyses show mixed results: A 2021 meta-analysis found benefit for nightmares (SMD = -0.75) 4, while a 2020 analysis showed improvement in nightmares but not overall sleep quality 5
4. Individual response varies greatly: Some patients respond dramatically, others not at all 1

Clinical Decision Framework

Consider prazosin if:

• Image rehearsal therapy unavailable, declined, or insufficient
• Nightmares causing significant occupational impairment
• No contraindications (severe hypotension, concurrent alpha-blockers)
• Patient understands this is off-label with mixed evidence

Do NOT use prazosin if:

• Patient has orthostatic hypotension or syncope history
• Already on multiple antihypertensives
• Hasn't tried evidence-based psychotherapy first

Bottom Line

While prazosin has a permissive "may be used" designation for nightmare disorder 1, the evidence is substantially stronger for PTSD-related nightmares than for occupational/idiopathic nightmares like this student's case. Image rehearsal therapy should be the first approach. If pharmacotherapy is needed, prazosin is a reasonable option with careful monitoring, but set realistic expectations given the mixed evidence base and recent guideline downgrades 1.